Tumor reactivity assessment using clonal expression (TRACE) reveals tumor reactive CD8+ T cell heterogeneity across solid tumors
The study introduces TRACE, a robust, open-source single-cell RNA sequencing classifier that accurately identifies tumor-reactive CD8+ T cells across diverse solid tumors without requiring dataset-specific training, thereby enabling the characterization of anti-tumor immune responses and their correlation with immunotherapy outcomes.